<div class="pk-crumbs" data-crumbs="[{&quot;label&quot;:&quot;Drugs&quot;,&quot;href&quot;:&quot;README.md&quot;},{&quot;label&quot;:&quot;B02B&quot;,&quot;href&quot;:&quot;atc/B02B.md&quot;},{&quot;label&quot;:&quot;coagulation factor VIII&quot;}]"></div>
<div class="pk-recnav" data-items="[{&quot;id&quot;:&quot;CoagulationFactorViii_Blanchette2021_reference&quot;,&quot;label&quot;:&quot;Blanchette_2021_reference&quot;,&quot;href&quot;:&quot;drugs/drug_coagulation_factor_viii/CoagulationFactorViii_Blanchette2021_reference.md&quot;,&quot;status&quot;:&quot;rejected&quot;,&quot;css&quot;:&quot;pk-badge--red&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;CoagulationFactorViii_Hua2019_reference&quot;,&quot;label&quot;:&quot;Hua_2019_reference&quot;,&quot;href&quot;:&quot;drugs/drug_coagulation_factor_viii/CoagulationFactorViii_Hua2019_reference.md&quot;,&quot;status&quot;:&quot;rejected&quot;,&quot;css&quot;:&quot;pk-badge--red&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;CoagulationFactorViii_Preijers2018_reference&quot;,&quot;label&quot;:&quot;Preijers_2018_reference&quot;,&quot;href&quot;:&quot;drugs/drug_coagulation_factor_viii/CoagulationFactorViii_Preijers2018_reference.md&quot;,&quot;status&quot;:&quot;rejected&quot;,&quot;css&quot;:&quot;pk-badge--red&quot;,&quot;here&quot;:false}]"></div>

# coagulation factor VIII

- **generic name:** coagulation factor VIII
- **ATC codes:** `B02BD02`
- **DrugBank:** [DB00025](https://go.drugbank.com/drugs/DB00025) · **PubChem:** not captured
- **groups:** approved, investigational

## About

**Description.** Human recombinant antihemophilic factor (AHF) or Factor VIII, 2332 residues, glycosylated, produced by CHO cells

**Indication.** The human recombinant antihemophilic factor is indicated for use in adults and children with hemophilia A for the control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.[L41025, L36130]

## Extraction summary

| extracted at | time | popPK e/r/o | PD e/r/o (paper) | PGx e/r/o | tokens in/out | LLM | papers | GROBID/JATS | OA/non-OA | NONMEM |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-18 20:48 | 1:05 | 0/3/0 | 0/0/0 | 0/0/0 | 31,677/2,177 | ollama / qwen3.8:27b-mtp-q8_0 | 1 | 0/1 | 1/0 | 0 |

## popPK records

| status | detail | model | model structure | params | citation | doi |
|---|---|---|---|---|---|---|
| <span class="pk-badge pk-badge--red">rejected</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss:120b (not confirmed, agreement 0.5). The first reading is what the record holds.">cross-check: disputed</span><br><sub>blocking: no structural parameters extracted (nothing to build)</sub><br><sub>route_to: `human_review`</sub> | [Blanchette_2021_reference](drugs/drug_coagulation_factor_viii/CoagulationFactorViii_Blanchette2021_reference.md) | — | 1-compartment (no model) | 0 | Blanchette VS et al., A Practical, One-Clinic Visit Protocol…, Thrombosis and haemostasis (2021) | [10.1055/a-1376-0970](https://doi.org/10.1055/a-1376-0970) |
| <span class="pk-badge pk-badge--red">rejected</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss:120b (not confirmed, agreement 0.5). The first reading is what the record holds.">cross-check: disputed</span><br><sub>blocking: no structural parameters extracted (nothing to build)</sub><br><sub>route_to: `human_review`</sub> | [Hua_2019_reference](drugs/drug_coagulation_factor_viii/CoagulationFactorViii_Hua2019_reference.md) | — | 1-compartment (no model) | 0 | Hua BL et al., [Population pharmacokinetics of two rec…, Zhonghua xue ye xue za zhi… (2019) | [10.3760/cma.j.issn.0253-2727.2019.08.009](https://doi.org/10.3760/cma.j.issn.0253-2727.2019.08.009) |
| <span class="pk-badge pk-badge--red">rejected</span> <span class="pk-badge pk-badge--red" title="re-read by gpt-oss:120b (not confirmed, agreement 0.4). The first reading is what the record holds.">cross-check: disputed</span><br><sub>blocking: no distribution volume and no clearance/elimination — not a compartmental popPK…</sub><br><sub>route_to: `human_review`</sub> | [Preijers_2018_reference](drugs/drug_coagulation_factor_viii/CoagulationFactorViii_Preijers2018_reference.md) | — | 1-compartment (no model) | 1 | Preijers T et al., Cross-evaluation of Pharmacokinetic-Gui…, Thrombosis and haemostasis (2018) | [10.1055/s-0038-1623531](https://doi.org/10.1055/s-0038-1623531) |

## ADME sites

Where this drug is handled, from DrugBank's curated enzymes / transporters / carriers and the KB's PGx genes, mapped to tissue through the ADME gene table. Compare it with other drugs on the [Sites & interactions](sites?drugs=coagulation_factor_viii) page (add drugs there; the set becomes a link).

| process | tissue | actors (role) | evidence |
|---|---|---|---|

<sub>Actors without a tissue in the table: ASGR2 (binder), CALR (chaperone), CANX (chaperone), F10 (activator), F2 (activator), F9 (cofactor), HSPA5 (chaperone), LMAN1 (binder), LMAN1 (transporter), LRP1 (modulator), MCFD2 (modulator), PHYH (target), PROC (substrate), VWF (binder).</sub>

<details class="legend">
<summary>Badge legend — what each badge means</summary>
<table><thead><tr><th>badge</th><th>what it means</th></tr></thead><tbody><tr><td><span class="pk-badge pk-badge--green">curated</span></td><td>hand-authored by a person — an exemplar, not an extraction.</td></tr><tr><td><span class="pk-badge pk-badge--green">extracted</span></td><td>the pipeline accepted the record: every closed-form check it could run passed.</td></tr><tr><td><span class="pk-badge pk-badge--green">reviewed — candidate</span></td><td>the reviewer ran the built model against the paper's own reported values and they agree — the best automatic verdict there is.</td></tr><tr><td><span class="pk-badge pk-badge--green">accepted (caveats)</span></td><td>the model replicates the paper, but an advisory check failed — the record page names the caveat under the badge and the drug page shows it under the status.</td></tr><tr><td><span class="pk-badge pk-badge--orange">needs review</span></td><td>extracted, then a check failed or a value looks implausible. The numbers are shown as read, not endorsed.</td></tr><tr><td><span class="pk-badge pk-badge--orange">built, not shipped</span></td><td>a model was built, but a core parameter fell back to a library default, so it is not shipped.</td></tr><tr><td><span class="pk-badge pk-badge--red">rejected</span></td><td>not accepted — the record is not a compartmental model, or nothing usable was extracted.</td></tr><tr><td><span class="pk-badge pk-badge--neutral">not modelled</span></td><td>pipeline state, not a judgement: no model has been built for this record yet (likewise `not simulated`).</td></tr><tr><td><span class="pk-badge pk-badge--stale">stale</span></td><td>the reviewer's verdict predates the latest re-run of the paper — treat the status as out of date, not as current.</td></tr><tr><td><span class="pk-badge pk-badge--green">cross-checked ✓</span></td><td>every independent reader agreed on every compared field. With more than one reader the badge counts them, e.g. 'cross-checked ✓ 2/2'.</td></tr><tr><td><span class="pk-badge pk-badge--orange">cross-check: partial</span></td><td>a reader differs on a non-structural field (a population label, a flag), or the readers do not all agree with each other.</td></tr><tr><td><span class="pk-badge pk-badge--red">cross-check: disputed</span></td><td>at least one reader differs on a structural parameter — a clearance, a volume, ka, a lag. The record still holds the FIRST reading; the disagreement is a signal for a reviewer, never an automatic correction.</td></tr></tbody></table>
<p><small>The first badge is the record's <b>status</b> — what the pipeline and the reviewer concluded. A second badge, when present, is the <b>cross-check</b>: whether a model of another family, re-reading the same paper, extracted the same numbers. They are independent — a rejected record can be cross-checked, and a confirmed reading can still fail a plausibility check.</small></p>
</details>

## Coverage

- **PubMed hits:** 32 matched, 12 returned
- **screened:** 3  ·  **relevant:** 3
- **records:** 3  ·  extracted 0  ·  needs_review 0  ·  rejected 3  ·  stale 0
- **scholar-agent fallback query used:** not captured

## Full text wanted

_7 paper(s) judged relevant from the abstract, with no full text on disk — paywalled, or the resolver could not reach them. Follow the DOI, then save the PDF into `papers/` as `&lt;save as&gt;.pdf` and re-run the extraction._

| save as | citation | domain | score | DOI | PubMed | why wanted |
|---|---|---|---|---|---|---|
| `Jiménez-Yuste_2015.pdf` | Jiménez-Yuste V et al., The pharmacokinetics of a B-domain trun…, Journal of thrombosis and h… (2015) | popPK | 10 | [10.1111/jth.12816](https://doi.org/10.1111/jth.12816) | [25495795](https://pubmed.ncbi.nlm.nih.gov/25495795) | The paper is a population PK study of coagulation factor VIII (turoctocog alfa), but the provided evidence contains only qualitative descriptions and no specific numeric parameter values. |
| `Zhang_2017.pdf` | Zhang Y et al., Population pharmacokinetics of recombin…, Journal of thrombosis and h… (2017) | popPK | 10 | [10.1111/jth.13662](https://doi.org/10.1111/jth.13662) | [28244200](https://pubmed.ncbi.nlm.nih.gov/28244200) | The paper describes a population PK model for coagulation factor VIII, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence text. |
| `Di_2007.pdf` | Di Paola J et al., ReFacto and Advate: a single-dose, rand…, Haemophilia : the official… (2007) | popPK | 9 | [10.1111/j.1365-2516.2006.01420.x](https://doi.org/10.1111/j.1365-2516.2006.01420.x) | [17286764](https://pubmed.ncbi.nlm.nih.gov/17286764) | The paper describes a pharmacokinetic study of Factor VIII (ReFacto and Advate) in humans, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence text. |
| `Preijers_2018.pdf` | Preijers T et al., Cross-evaluation of Pharmacokinetic-Gui…, Thrombosis and haemostasis (2018) | popPK | 9 | [10.1055/s-0038-1623531](https://doi.org/10.1055/s-0038-1623531) | [29534249](https://pubmed.ncbi.nlm.nih.gov/29534249) | The study reports quantitative PK parameters (half-life, time to trough) for Factor VIII in a clinical population, with specific numeric values provided in the text. |
| `Hua_2019.pdf` | Hua BL et al., [Population pharmacokinetics of two rec…, Zhonghua xue ye xue za zhi… (2019) | popPK | 8 | [10.3760/cma.j.issn.0253-2727.2019.08.009](https://doi.org/10.3760/cma.j.issn.0253-2727.2019.08.009) | [31495135](https://pubmed.ncbi.nlm.nih.gov/31495135) | The paper reports quantitative population pharmacokinetic parameters (half-life and time to activity threshold) for coagulation factor VIII preparations in hemophilia A patients. |
| `Kim_2024.pdf` | Kim MS et al., Kinetic Modeling for BT200 to Predict t…, The AAPS journal (2024) | popPK | 8 | [10.1208/s12248-024-00952-4](https://doi.org/10.1208/s12248-024-00952-4) | [38992298](https://pubmed.ncbi.nlm.nih.gov/38992298) | The paper describes a population PK/PD model for FVIII, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence text. |
| `Lissitchkov_2017.pdf` | Lissitchkov T et al., PK-guided personalized prophylaxis with…, Haemophilia : the official… (2017) | popPK | 8 | [10.1111/hae.13251](https://doi.org/10.1111/hae.13251) | [28452151](https://pubmed.ncbi.nlm.nih.gov/28452151) | The study is a PK-guided trial for coagulation_factor_viii (Nuwiq) involving individual PK modeling, but the evidence text only reports dosing intervals and bleeding rates, lacking specific numeric PK parameter values (CL, V, t1/2). |

<sub>queue written 2026-09-18T20:47:52.665749+00:00</sub>

## Screened and excluded

| domain | paper | verdict | relevance | extractability | reason |
|---|---|---|---|---|---|
| popPK | Bauer_2023 | irrelevant | 2 | 0 | The study focuses on von Willebrand factor (VWF) as the subject drug, with Factor VIII serving only as a pharmacodynamic marker or co-administered comparator, and no quantitative PK parameters for Factor VIII are provided in the evidence. |
| popPK | Di_2007 | relevant | 9 | 0 | The paper describes a pharmacokinetic study of Factor VIII (ReFacto and Advate) in humans, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence text. |
| popPK | Jiménez-Yuste_2015 | relevant | 10 | 0 | The paper is a population PK study of coagulation factor VIII (turoctocog alfa), but the provided evidence contains only qualitative descriptions and no specific numeric parameter values. |
| popPK | Kim_2024 | relevant | 8 | 0 | The paper describes a population PK/PD model for FVIII, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence text. |
| popPK | Lissitchkov_2017 | relevant | 8 | 2 | The study is a PK-guided trial for coagulation_factor_viii (Nuwiq) involving individual PK modeling, but the evidence text only reports dosing intervals and bleeding rates, lacking specific numeric PK parameter values (CL, V, t1/2). |
| popPK | Zhang_2017 | relevant | 10 | 0 | The paper describes a population PK model for coagulation factor VIII, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence text. |

---
<sub>Generated by `docs.py` (scholarv2) · newest extraction 2026-09-18 20:48 UTC</sub>
